Abstract

BackgroundThe mouse mammary tumor virus (MMTV) is unique from other retroviruses in having multiple viral promoters, which can be regulated by hormones in a tissue specific manner. This unique property has lead to increased interest in studying MMTV replication with the hope of developing MMTV based vectors for human gene therapy. However, it has recently been reported that related as well as unrelated retroviruses can cross-package each other's genome raising safety concerns towards the use of candidate retroviral vectors for human gene therapy. Therefore, using a trans complementation assay, we looked at the ability of MMTV RNA to be cross-packaged and propagated by an unrelated primate Mason-Pfizer monkey virus (MPMV) that has intracellular assembly process similar to that of MMTV.ResultsOur results revealed that MMTV and MPMV RNAs could be cross-packaged by the heterologous virus particles reciprocally suggesting that pseudotyping between two genetically distinct retroviruses can take place at the RNA level. However, the cross-packaged RNAs could not be propagated further indicating a block at post-packaging events in the retroviral life cycle. To further confirm that the specificity of cross-packaging was conferred by the packaging sequences (ψ), we cloned the packaging sequences of these viruses on expression plasmids that generated non-viral RNAs. Test of these non-viral RNAs confirmed that the reciprocal cross-packaging was primarily due to the recognition of ψ by the heterologous virus proteins.ConclusionThe results presented in this study strongly argue that MPMV and MMTV are promiscuous in their ability to cross-package each other's genome suggesting potential RNA-protein interactions among divergent retroviral RNAs proposing that these interactions are more complicated than originally thought. Furthermore, these observations raise the possibility that MMTV and MPMV genomes could also co-package providing substrates for exchanging genetic information.

Highlights

  • The mouse mammary tumor virus (MMTV) is unique from other retroviruses in having multiple viral promoters, which can be regulated by hormones in a tissue specific manner

  • The results presented in this study strongly suggest that Mason-Pfizer monkey virus (MPMV) and MMTV are promiscuous in their ability to cross-package each other's genome and that interactions between retroviral RNAs

  • In vivo packaging and transduction assay for MMTV and MPMV To study cross-packaging between MMTV and MPMV, we used three-plasmid trans complementation assays developed earlier by our laboratory [20,21]

Read more

Summary

Introduction

The mouse mammary tumor virus (MMTV) is unique from other retroviruses in having multiple viral promoters, which can be regulated by hormones in a tissue specific manner This unique property has lead to increased interest in studying MMTV replication with the hope of developing MMTV based vectors for human gene therapy. The use of MMTV based vectors would provide tissue-specific and inducible expression of the therapeutic gene, and its non-primate nature may circumvent potential safety concerns. Such concerns include cross-packaging and copackaging of the transfer vector RNA genome by related primate retroviruses or retrovirus-like elements resulting in the generation of recombinant variants with unknown pathogenic potential

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call